RDNT vs DBVT vs ALKS vs SMID

For growth investors, Smith-Midland Corporation (SMID) is the stronger pick with 31.

8% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Smith-Midland Corporation (SMID) offers the better valuation at 24. 2x trailing P/E, making it the more compelling value choice. Analysts rate RadNet, Inc. (RDNT) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Smith-Midland Corporation (SMID) is the cheapest at 24.

2x versus Alkermes plc at 24. 8x.

Over the past 5 years, Smith-Midland Corporation (SMID) delivered a total return of +169.

4%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: SMID returned +1437% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

06β versus Smith-Midland Corporation's 1. 58β — meaning SMID is approximately 49% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 137% for RadNet, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Smith-Midland Corporation (SMID) is pulling ahead at 31.

8% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Smith-Midland Corporation grew EPS 866. 7% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, SMID leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Smith-Midland Corporation (SMID) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1437% 10Y return).

Both have compounded well over 10 years (SMID: +1437%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RDNT (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and SMID (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RDNT is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; SMID is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.